Trial Profile
Pharmacogenomics of Antiplatelet Response - I
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aspirin (Primary) ; Clopidogrel (Primary)
- Indications Coronary artery disease; Myocardial infarction; Stroke; Thrombosis
- Focus Pharmacodynamics; Pharmacogenomic
- Acronyms PARes-I
- 28 Mar 2013 Additional information taken from trial website.
- 28 Mar 2013 New trial record